Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
3.52B | 3.49B | 3.83B | 3.73B | 2.33B | Gross Profit |
850.00M | 798.92M | 1.16B | 1.05B | 600.30M | EBIT |
442.40M | 368.96M | 690.41M | 699.12M | 301.50M | EBITDA |
575.30M | 519.70M | 853.72M | 829.35M | 423.88M | Net Income Common Stockholders |
423.90M | 372.46M | 642.44M | 506.33M | 218.78M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.07B | 1.69B | 1.36B | 1.38B | 1.33B | Total Assets |
4.68B | 4.39B | 4.22B | 3.92B | 3.17B | Total Debt |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Debt |
-2.07B | -1.69B | -1.36B | -1.38B | -1.33B | Total Liabilities |
470.30M | 459.26M | 532.66M | 747.22M | 451.37M | Stockholders Equity |
4.21B | 3.93B | 3.69B | 3.18B | 2.72B |
Cash Flow | Free Cash Flow | |||
459.50M | 419.50M | 48.97M | 79.75M | 151.58M | Operating Cash Flow |
573.30M | 593.42M | 207.49M | 371.30M | 426.88M | Investing Cash Flow |
-55.30M | -137.47M | -140.92M | -262.52M | -235.50M | Financing Cash Flow |
-137.40M | -141.07M | -121.59M | -52.64M | -103.61M |
In the first quarter of 2025, China Sunsine Chemical Holdings Ltd. reported a slight increase in sales volume but a marginal decrease in sales revenue due to lower average selling prices, despite a 27% rise in net profit. The company faces intense competition in the Chinese rubber chemicals industry and challenges from global economic uncertainties, yet it remains committed to its strategy of ‘Sales and Production Equilibrium’ and enhancing internal efficiency. The company is also progressing with its capacity expansion plans, with a trial run of its Phase 2 IS project underway, expected to commence commercial production by the end of 2025.